BACITRACIN

Bedaquiline inhibits mycobacterial ATP synthase, used in MDR-TB. Benefits include strong bactericidal activity. Side effects include QT prolongation, nausea, and liver enzyme elevation. Only GMP materials will be supplied, logistics all according to GDP.

SKU: 75f7d0d72be1 Category: Tag:

Product Description


Mechanism of action

Bacitracin is a cyclic polypeptide antibiotic that inhibits bacterial cellwall synthesis by interfering with the dephosphorylation of bactoprenol pyrophosphate, a lipid carrier responsible for shuttling peptidoglycan precursors across the cytoplasmic membrane. By preventing regeneration of the bactoprenol carrier, bacitracin effectively halts polymerisation of the cell wall. The compound exhibits strong activity against Grampositive organisms.

Benefits and advantages

Widely used in cellwall biosynthesis research, membrane transport studies, peptidoglycan precursor trafficking models and investigations into lipidcycle antibiotics. Its mechanism provides key insights into carrierlipid biochemistry.

Side effects and risks

Bacitracin may cause nephrotoxicity, allergic dermatitis and local irritation. In concentrated form, it requires biologicalagent containment and careful dermal protection.

Only GMP materials will be supplied, logistics all according to GDP.

Datasheet


Molecular Formula

C66H103N17O16S

Molecular Weight

1422.7 g/mol

CAS Number

1405-87-4

Storage Condition

Bacitracin ophthalmic ointment should be stored at 15-30 °C.

Solubility

Freely soluble

Purity

Purity information is available upon request (COA).

Synonym

Fortracin; Bacitracina; Bacitracine; Bacitracinum; Parentracin

IUPAC/Chemical Name

(4R)-4-[[(2S)-2-[[(4R)-2-[(1S,2S)-1-amino-2-methylbutyl]-4,5-dihydro-1,3-thiazole-4-carbonyl]amino]-4-methylpentanoyl]amino]-5-[[(2S,3S)-1-[[(3S,6R,9S,12R,15S,18R,21S)-3-(2-amino-2-oxoethyl)-18-(3-aminopropyl)-12-benzyl-15-[(2S)-butan-2-yl]-6-(carboxymethyl)-9-(1H-imidazol-5-ylmethyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclopentacos-21-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-5-oxopentanoic acid

InChl Key

CLKOFPXJLQSYAH-ABRJDSQDSA-N

InChl Code

InChI=1S/C66H103N17O16S/c1-9-35(6)52(69)66-81-48(32-100-66)63(97)76-43(26-34(4)5)59(93)74-42(22-23-50(85)86)58(92)83-53(36(7)10-2)64(98)75-40-20-15-16-25-71-55(89)46(29-49(68)84)78-62(96)47(30-51(87)88)79-61(95)45(28-39-31-70-33-72-39)77-60(94)44(27-38-18-13-12-14-19-38)80-65(99)54(37(8)11-3)82-57(91)41(21-17-24-67)73-56(40)90/h12-14,18-19,31,33-37,40-48,52-54H,9-11,15-17,20-30,32,67,69H2,1-8H3,(H2,68,84)(H,70,72)(H,71,89)(H,73,90)(H,74,93)(H,75,98)(H,76,97)(H,77,94)(H,78,96)(H,79,95)(H,80,99)(H,82,91)(H,83,92)(H,85,86)(H,87,88)/t35-,36-,37-,40-,41+,42+,43-,44+,45-,46-,47+,48-,52-,53-,54-/m0/s1

References

https://pubchem.ncbi.nlm.nih.gov/compound/10909430;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download